Stratos Wealth Partners, Ltd. Novavax Inc Transaction History

Stratos Wealth Partners, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$36.28 - $75.29 $102,418 - $212,543	-2,823 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$69.73 - $142.9 $10,808 - $22,149	155 Added 5.81%	2,823 $208,000
Q4 2021 Jan 14, 2022	BUY	$134.56 - $217.97 $51,267 - $83,046	381 Added 16.66%	2,668 $382,000
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $87,299 - $132,854	491 Added 27.34%	2,287 $474,000
Q2 2021 Jul 19, 2021	BUY	$121.0 - $257.67 $217,316 - $462,775	1,796 New	1,796 $381,000
Q1 2021 Apr 27, 2021	SELL	$112.98 - $319.93 $249,685 - $707,045	-2,210 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$78.74 - $139.5 $174,015 - $308,295	2,210 New	2,210 $246,000
Q3 2020 Oct 29, 2020	SELL	$79.44 - $178.51 $349,138 - $784,551	-4,395 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$13.86 - $83.61 $60,914 - $367,465	4,395 New	4,395 $366,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.